Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Daniela Muhr"'
Autor:
Sabine Danzinger, Yen Yen Tan, Margaretha Rudas, Marie-Theres Kastner, Sigrid Weingartshofer, Daniela Muhr, Christian F. Singer
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background It is important to identify biomarkers associated with BRCA mutation in women with early breast cancer (BC) to improve early identification of mutation carriers. Thus, in this study, we examined the protein expression of claudin (
Externí odkaz:
https://doaj.org/article/a06f654a3ebf48279c9254127e383cce
Autor:
Christian F. Singer, Yen Y. Tan, Daniela Muhr, Christine Rappaport, Daphne Gschwantler‐Kaulich, Christoph Grimm, Stephan Polterauer, Georg Pfeiler, Andreas Berger, Muy‐Kheng M. Tea
Publikováno v:
Cancer Medicine, Vol 8, Iss 4, Pp 1875-1881 (2019)
Abstract We investigated the prevalence of germline BRCA mutations in a population‐based cohort of Austrian women diagnosed with ovarian cancer and its association with family history of cancer. We prospectively collected family pedigrees of 443 Au
Externí odkaz:
https://doaj.org/article/21f950c2b51e4300882dc4d88b599012
Autor:
Florian Reichl, Daniela Muhr, Katharina Rebhan, Gero Kramer, Shahrokh F. Shariat, Christian F. Singer, Yen Y. Tan
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 9, p 917 (2021)
BACKGROUND: Men with germline BRCA1/2 mutations are not well studied compared to their female counterparts. This study evaluates the cancer characteristics, family history of cancer, and outcomes of male BRCA1/2 mutation carriers. METHODS: All men wi
Externí odkaz:
https://doaj.org/article/9d89b685cdf8437d986c1899deab181c
Autor:
Daphne Gschwantler-Kaulich, Sigrid Weingartshofer, Christine Rappaport-Fürhauser, Robert Zeillinger, Dietmar Pils, Daniela Muhr, Elena I Braicu, Marie-Therese Kastner, Yen Y Tan, Lorenz Semmler, Jalid Sehouli, Christian F Singer
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0196142 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0189641.].
Externí odkaz:
https://doaj.org/article/ca2207fee9e34a6b8a9dd64a6547dc75
Autor:
Daphne Gschwantler-Kaulich, Sigrid Weingartshofer, Christine Rappaport-Fürhauser, Robert Zeillinger, Dietmar Pils, Daniela Muhr, Elena I Braicu, Marie-Therese Kastner, Yen Y Tan, Lorenz Semmler, Jalid Sehouli, Christian F Singer
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189641 (2017)
Screening for ovarian cancer (OC) in women at high risk consists of a combination of carbohydrate antigen 125 (CA125) and transvaginal ultrasound, despite their low sensitivity and specificity. This could be improved by the combination of several bio
Externí odkaz:
https://doaj.org/article/ca7f1e6c3ea0439892bfef5319ae8cf8
Autor:
Daphne Gschwantler-Kaulich, Thomas W Grunt, Daniela Muhr, Renate Wagner, Heinz Kölbl, Christian F Singer
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146311 (2016)
BACKGROUND:HER-targeted tyrosine kinase inhibitors (TKIs) have demonstrated pro-apoptotic and antiproliferative effects in vitro and in vivo. The exact pathways through which TKIs exert their antineoplastic effects are, however, still not completely
Externí odkaz:
https://doaj.org/article/e22a355ac6324d12826a2e604393ea9c
Publikováno v:
Cancer Research. 82:P4-12
Background: Breast cancer risk in BRCA mutation carriers is up to 10 times higher compared to the general population. To support these patients, it is imperative to understand the worry that these patients face when they find out that they are a path
Autor:
Johana A. Luna Coronell, Andreas Weinhäusel, István Gyurján, Sandra Rosskopf, Daniela Muhr, Christian F. Singer
Publikováno v:
Oncotarget
Background: Breast cancer is the most frequent and one of the most fatal malignancies among women. Within the concept of personalized medicine, molecular characterization of tumors is usually performed by analyzing somatic mutations, RNA gene express
Autor:
Shahrokh F. Shariat, Gero Kramer, Yen Y. Tan, Florian Reichl, Daniela Muhr, Christian F. Singer, Katharina Rebhan
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 917, p 917 (2021)
Volume 11
Issue 9
Journal of Personalized Medicine, Vol 11, Iss 917, p 917 (2021)
Volume 11
Issue 9
BACKGROUND: Men with germline BRCA1/2 mutations are not well studied compared to their female counterparts. This study evaluates the cancer characteristics, family history of cancer, and outcomes of male BRCA1/2 mutation carriers. METHODS: All men wi
Autor:
Marie-Theres Kastner, Margaretha Rudas, Daniela Muhr, Christian F. Singer, Sabine Danzinger, Yen Y. Tan, Sigrid Weingartshofer
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Background It is important to identify biomarkers associated with BRCA mutation in women with early breast cancer (BC) to improve early identification of mutation carriers. Thus, in this study, we examined the protein expression of claudin (CLDN) 3,